RIMIPUD CONSULTANCY LIMITED

Company number 14760315 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

RIMIPUD CONSULTANCY LIMITED - Analysis Report

Company Number: 14760315

Analysis Date: 2025-07-19 12:05 UTC

  1. Risk Rating: HIGH

The company exhibits significant solvency concerns, reflected by its negative net assets as of the latest financial year. The large amount of creditors falling due after more than one year compared to total assets indicates potential long-term debt pressures. Liquidity is also weak, with very low current assets relative to current liabilities and a negative net current asset position.

  1. Key Concerns:
  • Negative Net Assets: The latest accounts show net liabilities of £1,564, a sharp decline from a positive net asset position the prior year, indicating financial deterioration.
  • High Long-term Creditors: Creditors due after more than one year increased substantially from £770 to £2,138, suggesting rising debt obligations that may impair solvency.
  • Low Liquidity: Current assets dropped from £123 to £33 while current liabilities remained around £300, resulting in negative net current assets which threatens short-term cash flow sufficiency.
  1. Positive Indicators:
  • Active and Compliant Status: The company is active with no overdue filings, which suggests regulatory compliance and ongoing operations.
  • Stable Ownership and Control: The sole director and 75-100% shareholder is consistent and engaged in the company, potentially contributing to streamlined decision-making.
  • Micro-entity Filing: The company qualifies as a micro-entity, implying a small scale operation which may reduce operational complexity.
  1. Due Diligence Notes:
  • Investigate the nature and terms of the long-term creditors to assess repayment risk and covenant implications.
  • Review cash flow statements and management accounts (if available) to evaluate liquidity trends and operational cash generation.
  • Understand the business model and revenue streams given the company is newly incorporated (2023) and operating in the healthcare consultancy sector.
  • Confirm the absence of director disqualifications or legal proceedings that may affect governance or financial stability.
  • Explore the reasons behind the significant decline in net assets and current assets from 2024 to 2025.

Perspective: Investment Risk Assessor · Model: gpt-4.1-mini · Generated 19 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.